Furthermore, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), two common antihypertensive agents, have been found to be inversely associated with AAA mortality (58). The gene discussed is ACE; the disease is triple-A syndrome.